Integer Stock Down 28% as Insider Reports Sale. Here's What to Know

Company Overview - Integer Holdings Corporation is a prominent global contract manufacturer in the medical device sector, utilizing its scale and technical expertise to provide high-value solutions to OEM customers [1] - The company has a diversified product range and operates in multiple regions, enabling it to support complex medical procedures and adapt to changing healthcare demands [1] Insider Trading Activity - On March 13, 2026, Tom Thomas, VP, Corporate Controller, reported the sale of 825 shares of Integer Holdings Corporation common stock in an open-market transaction [4] - This sale represented 15.85% of Thomas's direct holdings at the time, based on the share counts disclosed in the Form 4 [3] - The transaction is viewed as routine liquidity management rather than a sign of increased selling pressure, as it reflects ongoing liquidity management amid declining share capacity [2][5] Financial Performance - Integer reported approximately $1.85 billion in full-year 2025 sales, marking an 8% increase year-over-year, with adjusted operating income rising by 13% and adjusted EPS climbing by 21% [6] - Growth has been primarily driven by the cardio and vascular segment, benefiting from new product introductions and acquisitions, while other segments show mixed performance [6] Leverage and Financial Concerns - The company's leverage remains high at nearly 3.0 times EBITDA, with total debt increasing by $195 million to $1.185 billion at the end of the year [7] - The critical question for investors is whether Integer can convert consistent revenue growth into sustained margin expansion and improve its balance sheet, which is deemed more significant than the recent insider transaction [7]